Dengue Testing Market Size, Share, and Outlook, H2-2025 Report- By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others) and Companies, 2021-2032
Description
Dengue Testing Market Outlook
The global Dengue Testing Market Size is valued at $478.3 Million in 2025 and is forecast to reach $705.1 Million in 2032 at a CAGR of 5.7%.
The Dengue Testing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Dengue Testing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Dengue Testing Market Insights, 2025
The dengue testing market in 2025 is witnessing rapid advancements with the introduction of high-sensitivity rapid diagnostic tests (RDTs) and automated immunoassay platforms. Recent launches emphasize point-of-care devices capable of differentiating between dengue serotypes, enabling faster clinical decision-making and outbreak management. Companies are focusing on multiplexed assays that allow simultaneous detection of dengue and other arboviruses such as Zika and Chikungunya. Research efforts are directed toward digital integration, linking test results with health information systems for epidemiological tracking. Novel microfluidic and biosensor-based technologies are improving detection limits and reducing assay time. Regulatory emphasis on validation against reference standards and biosafety protocols is shaping product development. Emerging trends include portable, battery-operated devices suitable for field use in endemic regions. Collaborative initiatives with public health organizations are enhancing accessibility and adoption in low-resource settings.
Five Trends Shaping the Global Dengue Testing Market in 2025 and Beyond
The global Dengue Testing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Dengue Testing Industry?
The Dengue Testing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Dengue Testing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Dengue Testing Market Segment Insights
The Dengue Testing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Dengue Testing Industry Value Chain
The chapter identifies potential companies and their operations across the global Dengue Testing Industry ecosystem. It assists decision-makers in evaluating global Dengue Testing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Dengue Testing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Dengue Testing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Dengue Testing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Dengue Testing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Dengue Testing Market.
Europe Dengue Testing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Dengue Testing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Dengue Testing Industry competitiveness. The report analyses the key Dengue Testing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Dengue Testing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Dengue Testing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Dengue Testing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Dengue Testing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Dengue Testing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Dengue Testing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Abnova Corp, Certest Biotec SL, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Immundiagnostik AG, InBios International Inc, NovaTec Immundiagnostica GmbH, OriGene Technologies Inc, PerkinElmer Inc, Quest Diagnostics Inc, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Dengue Testing Market Scope
Leading Segments
By Product
ELISA-based Tests
RT-PCR based Tests
Dengue IgG/IgM Rapid Test
Others
By End-User
Hospitals
Diagnostic Centers
Others
Leading Companies
Abbott Laboratories
Abnova Corp
Certest Biotec SL
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
Immundiagnostik AG
InBios International Inc
NovaTec Immundiagnostica GmbH
OriGene Technologies Inc
PerkinElmer Inc
Quest Diagnostics Inc
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Dengue Testing Market Size is valued at $478.3 Million in 2025 and is forecast to reach $705.1 Million in 2032 at a CAGR of 5.7%.
The Dengue Testing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Dengue Testing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Dengue Testing Market Insights, 2025
The dengue testing market in 2025 is witnessing rapid advancements with the introduction of high-sensitivity rapid diagnostic tests (RDTs) and automated immunoassay platforms. Recent launches emphasize point-of-care devices capable of differentiating between dengue serotypes, enabling faster clinical decision-making and outbreak management. Companies are focusing on multiplexed assays that allow simultaneous detection of dengue and other arboviruses such as Zika and Chikungunya. Research efforts are directed toward digital integration, linking test results with health information systems for epidemiological tracking. Novel microfluidic and biosensor-based technologies are improving detection limits and reducing assay time. Regulatory emphasis on validation against reference standards and biosafety protocols is shaping product development. Emerging trends include portable, battery-operated devices suitable for field use in endemic regions. Collaborative initiatives with public health organizations are enhancing accessibility and adoption in low-resource settings.
Five Trends Shaping the Global Dengue Testing Market in 2025 and Beyond
The global Dengue Testing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Dengue Testing Industry?
The Dengue Testing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Dengue Testing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Dengue Testing Market Segment Insights
The Dengue Testing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others), By End-User (Hospitals, Diagnostic Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Dengue Testing Industry Value Chain
The chapter identifies potential companies and their operations across the global Dengue Testing Industry ecosystem. It assists decision-makers in evaluating global Dengue Testing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Dengue Testing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Dengue Testing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Dengue Testing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Dengue Testing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Dengue Testing Market.
Europe Dengue Testing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Dengue Testing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Dengue Testing Industry competitiveness. The report analyses the key Dengue Testing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Dengue Testing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Dengue Testing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Dengue Testing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Dengue Testing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Dengue Testing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Dengue Testing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Abnova Corp, Certest Biotec SL, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Immundiagnostik AG, InBios International Inc, NovaTec Immundiagnostica GmbH, OriGene Technologies Inc, PerkinElmer Inc, Quest Diagnostics Inc, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Dengue Testing Market Scope
Leading Segments
By Product
ELISA-based Tests
RT-PCR based Tests
Dengue IgG/IgM Rapid Test
Others
By End-User
Hospitals
Diagnostic Centers
Others
Leading Companies
Abbott Laboratories
Abnova Corp
Certest Biotec SL
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
Immundiagnostik AG
InBios International Inc
NovaTec Immundiagnostica GmbH
OriGene Technologies Inc
PerkinElmer Inc
Quest Diagnostics Inc
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
189 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Dengue Testing Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Dengue Testing Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Dengue Testing Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Dengue Testing Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Dengue Testing Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Test
- Others
- By End-User
- Hospitals
- Diagnostic Centers
- Others
- 6. Global Dengue Testing Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Dengue Testing Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Dengue Testing Market Trends and Growth Opportunities
- 6.2.1 North America Dengue Testing Market Outlook by Type
- 6.2.2 North America Dengue Testing Market Outlook by Application
- 6.3 North America Dengue Testing Market Outlook by Country
- 6.3.1 The US Dengue Testing Market Outlook, 2021- 2032
- 6.3.2 Canada Dengue Testing Market Outlook, 2021- 2032
- 6.3.3 Mexico Dengue Testing Market Outlook, 2021- 2032
- 7. Europe Dengue Testing Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Dengue Testing Market Trends and Growth Opportunities
- 7.2.1 Europe Dengue Testing Market Outlook by Type
- 7.2.2 Europe Dengue Testing Market Outlook by Application
- 7.3 Europe Dengue Testing Market Outlook by Country
- 7.3.2 Germany Dengue Testing Market Outlook, 2021- 2032
- 7.3.3 France Dengue Testing Market Outlook, 2021- 2032
- 7.3.4 The UK Dengue Testing Market Outlook, 2021- 2032
- 7.3.5 Spain Dengue Testing Market Outlook, 2021- 2032
- 7.3.6 Italy Dengue Testing Market Outlook, 2021- 2032
- 7.3.7 Russia Dengue Testing Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Dengue Testing Market Outlook, 2021- 2032
- 8. Asia Pacific Dengue Testing Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Dengue Testing Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Dengue Testing Market Outlook by Type
- 8.2.2 Asia Pacific Dengue Testing Market Outlook by Application
- 8.3 Asia Pacific Dengue Testing Market Outlook by Country
- 8.3.1 China Dengue Testing Market Outlook, 2021- 2032
- 8.3.2 India Dengue Testing Market Outlook, 2021- 2032
- 8.3.3 Japan Dengue Testing Market Outlook, 2021- 2032
- 8.3.4 South Korea Dengue Testing Market Outlook, 2021- 2032
- 8.3.5 Australia Dengue Testing Market Outlook, 2021- 2032
- 8.3.6 South East Asia Dengue Testing Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Dengue Testing Market Outlook, 2021- 2032
- 9. South America Dengue Testing Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Dengue Testing Market Trends and Growth Opportunities
- 9.2.1 South America Dengue Testing Market Outlook by Type
- 9.2.2 South America Dengue Testing Market Outlook by Application
- 9.3 South America Dengue Testing Market Outlook by Country
- 9.3.1 Brazil Dengue Testing Market Outlook, 2021- 2032
- 9.3.2 Argentina Dengue Testing Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Dengue Testing Market Outlook, 2021- 2032
- 10. Middle East and Africa Dengue Testing Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Dengue Testing Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Dengue Testing Market Outlook by Type
- 10.2.2 Middle East and Africa Dengue Testing Market Outlook by Application
- 10.3 Middle East and Africa Dengue Testing Market Outlook by Country
- 10.3.1 Saudi Arabia Dengue Testing Market Outlook, 2021- 2032
- 10.3.2 The UAE Dengue Testing Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Dengue Testing Market Outlook, 2021- 2032
- 10.3.4 South Africa Dengue Testing Market Outlook, 2021- 2032
- 10.3.5 Egypt Dengue Testing Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Dengue Testing Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Abnova Corp
- Certest Biotec SL
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd
- Immundiagnostik AG
- InBios International Inc
- NovaTec Immundiagnostica GmbH
- OriGene Technologies Inc
- PerkinElmer Inc
- Quest Diagnostics Inc
- Thermo Fisher Scientific Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
